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Microbiology, The University of Hong Kong, Hong Kong Special Administrative Region, ChinaAbstractPrevalence of disseminated Penicillium marneffei infection is not known in human immunodeﬁciency virus (HIV)-infected patients. This
retrospective study aimed to evaluate the prevalence of and risk factors for disseminated P. marneffei infection in HIV-infected patients
during 2004–11 in Guangzhou, China. We tested 8131 archived HIV-infected patient serum samples for P. marneffei-speciﬁc
mannoprotein (Mp1p) antigen using a highly sensitive and speciﬁc ELISA that we previously established. The CD4 count of 2686 cases
was determined by ﬂow cytometry. Logistic regression was used to assess predictors of Mp1p antigenaemia. The overall prevalence of
disseminated penicilliosis as detected by positive serum Mp1p antigen was 9.36% (761/8131), in good concordance with Platelia™
Aspergillus immunoassay. During 2004–11, the prevalence increased to a peak of 12.58% (158/1256) in 2010 and decreased in 2011.
Penicilliosis was strongly associated with progression from HIV to AIDS (OR 4.66, 95% CI 3.94–5.51, p <0.001) and humidity (OR 1.02,
95% CI 1.01–1.03, p 0.002). Disseminated penicilliosis occurred mainly during the rainy seasons (p <0.001). For 2686 cases with known
CD4 count, logistic regression showed that CD4 count of <200 cells/μL was a risk factor for penicilliosis (OR 2.90, 95% CI 1.10–7.66, p
0.032), especially when it was <50 cells/μL (OR 24.26, 95% CI 10.63–55.36, p <0.001) during which 28.06% of patients developed
disseminated penicilliosis. In conclusion, approximately 9.36% of the HIV-infected patients in our study developed disseminated
penicilliosis. Rapid diagnosis may be achieved by performing serological surveillance for Mp1p antigenaemia as a routine procedure for all
HIV-infected patients with CD4 count of <50 cells/μL.
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p://dx.doi.org/10.1016/j.cmi.2014.12.014IntroductionPenicillium marneffei is an emerging fungus endemic to South
East Asian regions, including southern China, Thailand and
Vietnam [1]. Penicilliosis, a systemic disease caused by
P. marneffei, mainly occurs in immunocompromised patients,
particularly those with AIDS and other forms of cell-mediated
immunodeﬁciencies [2–5]. Penicilliosis is classiﬁed as an
AIDS-deﬁning illness [6], and its prevalence has increased in
parallel with that of human immunodeﬁciency virus (HIV)ious Diseases. Published by Elsevier Ltd. All rights reserved
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icilliosis in AIDS patients requiring hospitalization were re-
ported, varying from 4.4% in Vietnam to 14% in Hong Kong
[7,8], but it has not been reported in mainland China, espe-
cially for HIV-infected patients, including both outpatients and
inpatients. Factors that affect the prevalence include environ-
mental predictors, seasonality and changes in CD4 count [7,9].
HIV-infected patients who have a CD4 count of <200 cells/μL
are at a particularly high risk for developing the disease [10].
However, the prevalence and characteristics of penicilliosis in
HIV-infected patients, especially in Chinese patients with
different CD4 counts, is unknown. The relationship between
the prevalence of and common risk factors for penicilliosis in
HIV infection remains unclear. Previously, we demonstrated
that a cell-wall mannoprotein, Mp1p, could be a potential
biomarker for the serodiagnosis of penicilliosis [11–13]. Using
this protein, we established a double-antibody sandwich ELISA
for Mp1p antigen with high sensitivity and speciﬁcity [14]. In this
study, we used this immunoassay to assess the prevalence of
penicilliosis among HIV-infected patients in Guangzhou during
2004–11. The correlation between the CD4 count of our HIV-
infected patients and the seasonality with Mp1p antigen-positive
rate was also analysed.MethodsStudy design
A retrospective study was anonymously conducted to deter-
mine the prevalence of penicilliosis in HIV-infected patients. We
analysed the data of 8131 archived serum samples of HIV-
infected patients in Guangzhou from the Guangzhou Centre
for Disease Control and Prevention (GZCDC). These samples
were collected from 7734 patients over an 8-year period, and
there was at most only one sample for every patient in each
year. All patients admitted with HIV or AIDS from 1 January
2004 to 31 December 2011 with demographic information,
including sex, age and disease stage (HIV infection or AIDS)
were included. HIV-1 infection was identiﬁed by routine blood-
screening procedures and conﬁrmed by Western blot analysis.
AIDS was deﬁned as positive HIV-1 serology with a CD4 count
<200 cells/μL. The archived sera were investigated for Mp1p
antigen by sandwich ELISA [14]. In the absence of reference
standard results for penicilliosis in these archived sera, we
conﬁrmed Mp1p antigen-positive sera by Platelia™ Aspergillus
enzyme immunoassay (Bio-Rad Laboratories, Redmond, WA,
USA), a commercial kit for galactomannan (GM), also positive
for penicilliosis [15], and calculated the concordance rate be-
tween Mp1p and GM. Patients with disseminated penicilliosis
were deﬁned as having an Mp1p antigen-positive serum, whichClinical Microbiology and Infection © 2014 European Society of Clinical Microbiologyindicated active infection with antigenaemia. Only 2686 out of
8131 cases had available CD4 counts. The average temperature
and relative humidity for every month in Guangzhou were
collected by the Guangdong Meteorological Service. The study
was approved by the Ethics Committee of the Zhujiang Hospital
of Southern Medical University.
HIV-1 test and CD4 cell count
Specimens were screened for the HIV antibody by using two
ELISA kits (BioMérieux, Boxtel, the Netherlands; Beijing
BGIGBI Biotech, Beijing, China). If either of the ELISAs was
positive, a Western blot test was conducted for conﬁrmation
(MP Biomedicals Asia Paciﬁc Pte Ltd, Singapore). Whole blood
was collected from HIV-infected patients into vials containing
EDTA. CD4 counts were analysed by ﬂow cytometry (FACS
Calibur™, BD, Franklin Lakes, NJ, USA) as previously described
[16].
Double-antibody sandwich ELISA for Mp1p antigen
The procedure for the antigen capture ELISA was conducted as
described previously with small modiﬁcations [14]. Brieﬂy, ali-
quots of 100 μL/well of undiluted human sera were added to
microwell plates (Costar, Corning, NY, USA) coated with
capture antibodies and incubated at 37°C for 1 h. After the
plates were washed, biotinylated antibody (100 μL/well) was
added and incubated for 30 min at 26°C. Following incubation
with streptavidin–horseradish peroxidase (Sigma-Aldrich, St
Louis, MO, USA), tetramethylbenzidine substrate (KPL, Gai-
thersburg, MD, USA) was added. The reaction was stopped
after 10 min by the addition of 0.3 M sulphuric acid, and the
plates were then examined in an ELISA plate reader (Bio-Tek,
Winooski, VT, USA) at 450 nm.
Detection of GM
Galactomannan was detected in Mp1p antigenaemia sera using a
Platelia Aspergillus assay, according to the manufacturer’s in-
structions. Because there was no cut-off value for GM levels in
the diagnosis of penicilliosis, we analysed the results using three
different GM indices as a cut-off: 0.5, 1.0 and 1.5, as suggested
by instructions for other invasive fungal infections.
Statistical analysis
Instances of Mp1p antigenaemia in different months and years
were compared by χ2 test, and a two-sided p value of <0.05 was
considered signiﬁcant. The CD4 count was stratiﬁed into ﬁve
groups (0–50, 50–100, 100–200, 200–500 and >500 cells/μL).
Prevalences of disseminated penicilliosis (Mp1p antigen-positive
rate) among different groups were compared with χ2 test. A
two-sided p value of <0.05 was considered signiﬁcant. Logistic
regression was used to assess predictors of Mp1p antigenaemiaand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 484–489
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tatus with HIV/AIDS disease stage or CD4 counts, ambient
humidity and temperature. A value of p <0.05 was considered
signiﬁcant. Odds ratios were calculated, and were considered as
a risk predictor when OR >1.0. All statistical analyses were
performed using SPSS (version 11.5).ResultsFIG. 1. (a) Number of cases of penicilliosis diagnosed by Mp1p anti-
genaemia and human immunodeﬁciency virus (HIV) admissions in
Guangzhou during 2004–11. (b) Prevalence of penicilliosis diagnosed by
Mp1p antigenaemia in HIV-infected patients and proportions of different
stages of AIDS in different years.
TABLE 1. Positive rates of Mp1p antigen in HIV-infected
patients from Guangzhou during 2004–2011
Year No. of samples
Mp1p antigen positive
% (No. of samples)
2004 271 5.17 (14)
2005 527 6.45 (34)
2006 884 8.37 (74)
2007 894 9.62 (86)
2008 1221 9.42 (115)
2009 1284 10.28 (132)
2010 1256 12.58 (158)
2011 1794 8.25 (148)
Total 8131 9.36 (761)Laboratory features of patients
During 2004–11 in Guangzhou, a total of 8131 HIV-infected pa-
tient sera were tested. The patients were predominantly male
(male:female = 7.1:2.9), and the median age was 35 years (inter-
quartile range (IQR) 29–43 years). Overall, their HIV infection
was mainly sexually acquired (55.06%), but the route of acquisi-
tion changed throughout the years. Before 2007, more than
44.52% of HIV infections were acquired via blood product
transfusion, whereas more than 54.05% after 2007 were sexually
acquired. Overall, 53.98% (4389/8131) of all the HIV-infected
patients were in the HIV stage and 46.02% (3742/8131) had AIDS.
Prevalence of penicilliosis in HIV-infected patients
diagnosed by Mp1p antigenaemia test
Mp1p antigenaemia may be found in the active phase of acute or
reactivated P. marneffei infection. The number of cases of
penicilliosis increased signiﬁcantly throughout the study period,
in parallel with that of HIV infection (Fig. 1a). During the 8 years
of the study, the average prevalence of Mp1p antigenaemia was
9.36% (761/8131). It increased from 5.17% in 2004 to a peak of
12.58% in 2010, but decreased to 8.25% in 2011, which was still
higher than in 2004 (Table 1). There was signiﬁcant difference
in the prevalence (p <0.001) during the different years of the
study period, and the trend of prevalence was strongly asso-
ciated with the progression of HIV infection to AIDS as shown
in Fig. 1(b) (OR 4.66, 95% CI 3.94–5.51, p <0.001).
GM detection in Mp1p antigenaemia
Galactomannan was detected in 513 Mp1p antigenaemia serum
samples, to conﬁrm penicilliosis by Platelia Aspergillus kit. The
coincidence between Mp1p and GM was 86.55% (444/513),
73.88% (379/513) or 66.67% (342/513), when an index of 0.5,
1.0 or 1.5 is considered as positive, according to the in-
structions of the kit. The median GM index is 2.58 (IQR
0.88–6.21).
Prevalence of penicilliosis in patients with different
CD4 counts
Of 280 patients with Mp1p antigenaemia and 2406 without
Mp1p antigenaemia, the median CD4 counts were 15 cells/μLClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect(IQR 6–39 cells/μL) and 236.5 cells/μL (IQR 58–396 cells/μL),
respectively. Overall, 86.78% (243/280) and 78.57% (220/280)
of patients with penicilliosis had CD4 count of <100 cells/μL
and 50 cells/μL, respectively. Among those with a CD4 count ofious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 484–489
FIG. 2. Average prevalence of penicilliosis with Mp1p antigenaemia in
human immunodeﬁciency virus (HIV) -infected patients in different
months from 2004 to 2011.
CMI Wang et al. Penicilliosis in AIDS patients of Guangzhou 487<50 cells/μL, Mp1p antigenaemia accounted for 28.06% (220/
784), which is much higher than the rate of 1.65% (6/363) in
patients with a CD4 count of >500 cells/μL (p <0.001). The
results are shown in Table 2.
Among the 2686 patients with known CD4 count, logistic
regression analysis showed that a CD4 count of <200 cells/μL
was associated with penicilliosis (OR 2.90, 95% CI 1.10–7.66, p
0.032), and especially when it was <50 cells/μL (OR 24.26, 95%
CI 10.63–55.36, p <0.001).
The relationship between relative humidity or
temperature and penicilliosis in HIV-infected patients
in Guangzhou
The average relative humidity and temperature were collected
for each month of the year from the Guangdong Meteorological
Service. Mp1p antigenaemia rate for each month was calculated.
The highest rate of 13.84% was in April (Fig. 2) during the rainy
seasons in Guangzhou. There were signiﬁcant variations in the
rates among the 12 months of the year (p <0.001). The prev-
alence was higher during February to July than it was during the
other months, and it coincided with the changes in average
relative humidity. Logistic regression showed that Mp1p anti-
genaemia was related with humidity (OR 1.02, 95% CI
1.01–1.03, p 0.002) but not temperature (OR 1.01, 95% CI
0.99–1.02, p 0.455).DiscussionPenicilliosis is one of the most common opportunistic fungal
infections in HIV-infected patients in South East Asian regions,
including southern China [1]. The prevalence continues to in-
crease in parallel with the increasing number of cases of HIV
infection in these areas [1]. Cases of penicilliosis have also been
reported among visitors to South East Asia from countries
outside the region [17]. Lack of early and accurate diagnostic
tools leads to delayed treatment, which is associated with poor
clinical outcome. We previously developed a double sandwichTABLE 2. Prevalence of Mp1p antigenaemia in HIV-infected





(% no. of samples)
Mp1p antigen
negative group
(% no. of samples)
Total
(no. of samples)
 500 1.65 (6) 98.35 (357) 363
200 ~ 500 1.69 (17) 98.31 (991) 1008
100 ~ 200 4.53 (14) 95.47 (295) 309
50~100 10.36 (23) 89.63 (199) 222
< 50 28.06 (220) 71.94 (564) 784
Total 10.42 (280) 89.58 (2406) 2686
Clinical Microbiology and Infection © 2014 European Society of Clinical MicrobiologyELISA for Mp1p antigen with high sensitivity and speciﬁcity [14].
A modiﬁed method for detection in undiluted sera was used in
this study to enhance sensitivity, after non-speciﬁc binding was
excluded by preliminary tests. The speciﬁcity was found to be
98.81% (579/586) in 563 healthy human sera, and 23 blood-
culture-positive sera (14 samples from 14 candidiasis patients,
six samples from one fusaridiosis patient, three samples from
three cryptococcosis patients). The sensitivity was 100% (7/7)
among seven samples from six penicilliosis patients. There is no
signiﬁcant difference in detection performance between the
previous study [14] and this modiﬁed method. This work de-
termines the prevalence of active penicilliosis in Guangzhou and
evaluates risk factors for penicilliosis in HIV-infected patients.
Mp1p antigenaemia is usually found in patients with an active
infection, which can be acute or reactivated. The prevalence of
active and often disseminated disease is evaluated by the Mp1p
antigenaemia test. Among HIV-infected patient serum samples
collected during 2004–11, the average prevalence of active
penicilliosis was 9.36% (761/8131). This result was different
from Thuy Le’s report [7], in which prevalence was approxi-
mately 4.4% in AIDS patients in Vietnam. This discrepancy may
be related to the different demographics among HIV pop-
ulations and their exposure to P. marneffei. Another possible
reason may be that our immunoassays are more sensitive than
blood culture and other diagnostic methods.
Mp1p antigenaemia was further conﬁrmed by detection of
GM with the Platelia Aspergillus kit. A good concordance rate
between Mp1p and GM was observed, which is similar to that
reported in Taiwan [15]. But we could not exclude other
possible reasons for cross-reactivity in the GM assay, especially
the use of piperacillin-tazobactam, amoxicillin-clavulanate
[18,19], in HIV-infected patients with opportunistic infections.
The prevalence of histoplasmosis, which causes a positive GMand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 484–489
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Moreover, aspergillosis is rare in HIV-infected people [22]. As
for cryptococcosis. which also may give rise to a positive GM
result, we found that cryptococcosis patient sera were negative
when tested by our Mp1p antigen assay.
The trend of active penicilliosis over the 8 years in the study
period was shown in Table 1. The prevalence increased to a
peak in 2010 before decreasing in 2011. This behaviour may be
related to HIV populations with varying disease stages. The
increase of active penicilliosis was positively correlated with the
proportion of HIV-infected patients at the AIDS stage, and
negatively correlated with the proportion at the HIV infection
stage. This result indicates that the prevalence of active pen-
icilliosis is associated with CD4 count. HIV-infected patients
with CD4 count <50 cells/μL are prone to developing co-
infections with various opportunistic fungal infections. In this
study, we found that the median CD4 count of patients with
penicilliosis was 15 cells/μL (IQR 6–39 cells/μL), among whom
78.57% had a CD4 count of <50 cells/μL. Mp1p antigenaemia
usually occurred when the CD4 count was <50 cells/μL. We
stratiﬁed the CD4 count into ﬁve levels, and calculated the
prevalence of penicilliosis in each level. Among those with a
CD4 count of <50 cells/μL, 28.06% developed penicilliosis.
In addition to the CD4 count, seasonality was reported to be
associated with the prevalence of penicilliosis [7,9]. In
Guangzhou, warm and humid weather is especially suitable for
the growth of fungi. In this study, we studied the relationship
among the Mp1p antigen, humidity and temperature. Our re-
sults show that the prevalence of active penicilliosis is associ-
ated with humidity, but not temperature. These results are in
accord with those from a previous study [9].
Besides Mp1p antigen, Mp1p antibody should be detected for
diagnosis of penicilliosis. We tried to determine this in all 8131
samples by double antigen sandwich ELISA [23], but obtained a
low detection rate (data was not shown). Our considerations
or desynchrony of antigen and antibody detection are as fol-
lows: (i) the different phases for appearance of antigen and
antibody; (ii) an overwhelmingly high amount of antigen may
consume most antibodies which inﬂuences antibody detection
by immunological method; (iii) some patients may be not able
to mount an adequate antibody response due to immunosup-
pression. Therefore, we would redesign the dynamics obser-
vation to characterize Mp1p antibody in penicilliosis.
Our study has some limitations. First, few consecutive serum
samples and CD4 count data were available, which prevented
us from monitoring the temporal changes in Mp1p antigen, and
their relationships with CD4 count. Second, specimens were
collected from the outpatient clinics of GZCDC, where the
clinical details including other opportunistic infections, anti-
fungal treatments and prophylaxis might be incomplete. Third,Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectin a retrospective study, reference standards such as those for
culture, histology and cytology were hard to use to conﬁrm
Mp1p antigenaemia results. However, a diagnostic Platelia
Aspergillus kit was used, and there was good accordance be-
tween the GM and Mp1p antigenaemia tests. Fourth, we did not
differentiate penicilliosis from histoplasmosis, although there is
very low prevalence of histoplasmosis in China [21].
In conclusion, the prevalence of penicilliosis was approxi-
mately 9.36% in Guangzhou, China during 2004–11. Most cases
of penicilliosis occurred in patients with CD4 count of
<50 cells/μL during the rainy season. As an important oppor-
tunistic infection in HIV-infected patients in Guangzhou,
increased clinical vigilance for the diagnosis of penicilliosis is
needed. Penicilliosis can be fatal without timely and appropriate
treatment, especially in AIDS patients. Our immunoassay was
high throughput and easy to perform, and would serve as a
good serodiagnostic tool for penicilliosis in HIV-infected pa-
tients. Serum Mp1p antigen screening in HIV-infected patients,
especially in those with CD4 count of <50 cells/μL, may pre-
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